PSNYW vs TSLA

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 3/9 and a complete absence of a Graham Number due to negative earnings and equity. The company is facing a severe liquidity crisis with a current ratio of 0.43 and a quick ratio of 0.21, indicating an inability to meet short-term obligations. Most alarmingly, the gross margin is -32.68%, meaning the company loses money on every vehicle produced before operating expenses. While revenue growth remains positive at 26.10%, the negative Price/Book ratio (-0.06) and bearish technical trend (0/100) suggest a high risk of insolvency or massive dilution.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.